HIV Mutation Detail Information

> V108V Search Result

Mutation Information

Mutation Site	V108V
Mutation Type	Amino acid level
Gene/Protein/Region Type	RT
Relevant Drug	rilpivirine (RPV);cabotegravir (CAB);dolutegravir (DTG)
Country	Russia

Literature Information

PubMed PMID	33136751
Disease	HIV infection/AIDS
Published Year	2020
Journal	Journal of acquired immune deficiency syndromes (1999)
Title	Long-Acting Injectable Cabotegravir + Rilpivirine for HIV Maintenance Therapy: Week 48 Pooled Analysis of Phase 3 ATLAS and FLAIR Trials.
Author	Rizzardini G,Overton ET,Orkin C,Swindells S,Arasteh K,Górgolas Hernández-Mora M,Pokrovsky V,Girard PM,Oka S,Andrade-Villanueva JF,Richmond GJ,Baumgarten A,Masiá M,Latiff G,Griffith S,Harrington CM,Hudson KJ,St Clair M,Talarico CL,Patel P,Cutrell A,Van Eygen V,D'Amico R,Mrus JM,Wu S,Ford SL,Chow K,Roberts J,Wills A,Walters N,Vanveggel S,Van Solingen-Ristea R,Crauwels H,Smith KY,Spreen WR,Margolis DA
Evidence	TABLE 3

Contents
Description

Mutation Information Note

Gene/Protein/Region Type: Virus Gene (e.g. LMP-1) or Virus Protein (e.g. Rep 68) or Virus Region (e.g. S, X)

Literature Information Note

Evidence: sentence contains this mutation information in the citation